EXL — Elixinol Wellness Cashflow Statement
0.000.00%
Last trade - 00:00
- AU$7.59m
- AU$8.21m
- AU$8.48m
- 23
- 55
- 31
- 30
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Changes in Working Capital | 0.679 | 0.465 | 0.405 | 0.386 | 1.56 |
Other Operating Cash Flow | |||||
Cash from Operating Activities | -51.1 | -22.6 | -14.1 | -8.15 | -2.76 |
Capital Expenditures | -11.1 | -0.328 | -0.292 | -0.012 | -0.017 |
Purchase of Fixed Assets | |||||
Purchase / Acquisition of Intangibles | |||||
Other Investing Cash Flow Items | -6.79 | 2.88 | 0.464 | -0.857 | -1.03 |
Sale of Business | |||||
Sale of Fixed Assets | |||||
Sale/Maturity of Investment | |||||
Purchase of Investments | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -17.9 | 2.55 | 0.172 | -0.869 | -1.04 |
Financing Cash Flow Items | -2.83 | -2.52 | -0.11 | 0 | -0.199 |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 46.4 | 27.5 | -1.16 | -0.757 | 1.61 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | -22.5 | 7.37 | -15.1 | -9.79 | -2.16 |